Empagliflozin trials for Chronic kidney disease

All Empagliflozin trials · All Chronic kidney disease trials

Phase breakdown

Recruiting trials studying Empagliflozin for Chronic kidney disease

• A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
  NCT07107945 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 93 locations
• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
  NCT06531824 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 557 locations
• Empagliflozin Treatment in Kidney Transplant Recipients
  NCT06013865 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 5 locations

Common questions

How many trials study Empagliflozin for Chronic kidney disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.